{"id":"tp-29259","type":"article-newspaper","title":"CytoMed Therapeutics Gets Nasdaq Notice Over $1 Bid Deficiency","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/29259","datePublished":"2026-10-09T20:51:27.000Z","dateModified":"2026-10-09T20:51:27.000Z","language":"en","abstract":"The company has until April 5, 2027, to restore compliance after its closing bid price remained below $1 for 30 consecutive business days.","section":"Business","references":[]}